1. Prognostic Significance of Inflammation-based Scores in Pancreatic Cancer Patients Treated With Palliative Chemotherapy: A Single Institution Experience.
- Author
-
Liberko M, Sychra T, Oliverius M, and Soumarová R
- Subjects
- Humans, Female, Male, Prognosis, Aged, Middle Aged, Gemcitabine, Fluorouracil administration & dosage, Fluorouracil therapeutic use, Deoxycytidine analogs & derivatives, Deoxycytidine administration & dosage, Deoxycytidine therapeutic use, Paclitaxel administration & dosage, Irinotecan administration & dosage, Irinotecan therapeutic use, Leucovorin administration & dosage, Leucovorin therapeutic use, Adult, Oxaliplatin administration & dosage, Oxaliplatin therapeutic use, Kaplan-Meier Estimate, Neutrophils pathology, Albumins administration & dosage, Aged, 80 and over, Pancreatic Neoplasms drug therapy, Pancreatic Neoplasms mortality, Pancreatic Neoplasms pathology, Palliative Care methods, Inflammation pathology, Inflammation drug therapy, Antineoplastic Combined Chemotherapy Protocols therapeutic use
- Abstract
Background/aim: Inflammation-based prognostic scores have shown prognostic significance and have been associated with clinical outcomes in various types of cancer. Inflammation is known to promote tumor progression leading to reduced survival. In pancreatic cancer, systemic inflammation is common and contributes to its dismal prognosis. Although the prognosis of pancreatic cancer is improving with the introduction of new drugs, the prognostic indicators are still poorly understood. The present study aimed to evaluate inflammation-based prognostic scores in patients with metastatic pancreatic cancer receiving first-line chemotherapy., Patients and Methods: A total of 43 patients with metastatic pancreatic cancer undergoing first-line chemotherapy (gemcitabine+nab-paclitaxel and mFOLFIRINOX) in our institution were analyzed. Baseline clinicopathological and pre-treatment laboratory data were collected. Survival was estimated using the Kaplan-Meier method and survival differences were evaluated using the log-rank test., Results: In the whole cohort, we identified lymphocyte-to-monocyte ratio ≥3, systemic inflammatory response index <2.3, carcinoembryonic antigen <2.5, neutrophil-to-lymphocyte ratio <5, Memorial Sloane Kettering score <2, and prognostic index <2 as prognostic markers associated with improved overall survival in patients receiving first-line chemotherapy., Conclusion: The current analysis showed an association between inflammatory-based prognostic markers and overall survival in patients with metastatic pancreatic cancer treated in a real-world setting at a single institution., (Copyright © 2024, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF